Coffee consumption and bladder cancer: A meta-analysis of observational studies

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Wu, Weixiang ^a   Tong, Yeqing ^b   Zhao, Qiang ^a   Yu, Guangxia ^a   Wei, Xiaoyun ^a   Lu, Qing ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COFFEE;

ADVERSE EFFECTS; CASE CONTROL STUDY; COFFEE; COHORT ANALYSIS; FEMALE; HUMAN; MALE; META ANALYSIS; ODDS RATIO; PUBLISHING; RISK; SEX DIFFERENCE; URINARY BLADDER NEOPLASMS;

CASE-CONTROL STUDIES; COFFEE; COHORT STUDIES; FEMALE; HUMANS; MALE; ODDS RATIO; PUBLICATION BIAS; RISK; SEX FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84924897996     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09051     Document Type: Article

References (60)

1. Jemal, A. et al. Global cancer statistics. CA Cancer J Clin 61, 69-90 (2011).
2. Leppert, J. T. et al. Prevention of bladder cancer: a review. Eur Urol 49, 226-234 (2006).
3. Botteman, M. F., Pashos, C. L., Redaelli, A., Laskin, B. & Hauser, R. The health economics of bladder cancer. Pharmacoeconomics 21, 1315-1330 (2003).
4. Boyle, P. & Levin, B. World cancer report 2008. (IARC Press, International Agency for Research on Cancer, 2008).
5. Burger, M. et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63, 234-241 (2013).
6. Porta, M. et al. Coffee drinking: the rationale for treating it as a potential effect modifier of carcinogenic exposures. Eur J Epidemiol 18, 289-298 (2003).
7. Huber, W. W. et al. Coffee and its chemopreventive components Kahweol and Cafestol increase the activity of O6-methylguanine-DNA methyltransferase in rat liver - comparison with phase II xenobiotic metabolism. Mutat Res 522, 57-68 (2003).
8. Cavin, C. et al. Induction of Nrf2-mediated cellular defenses and alteration of phase I activities as mechanisms of chemoprotective effects of coffee in the liver. Food Chem Toxicol 46, 1239-1248 (2008).
9. Ramos, S. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol Nutr Food Res 52, 507-526 (2008).
10. Cole, P. Coffee-drinking and cancer of the lower urinary tract. Lancet 1, 1335-1337 (1971).
11. Cartwright, R. A., Adib, R., Glashan, R. & Gray, B. K. The epidemiology of bladder cancer in West Yorkshire. A preliminary report on non-occupational aetiologies. Carcinogenesis 2, 343-347 (1981).
12. Hartge, P., Hoover, R., West, D. W. & Lyon, J. L. Coffee drinking and risk of bladder cancer. J Natl Cancer Inst 70, 1021-1026 (1983).
13. Clavel, J. & Cordier, S. Coffee consumption and bladder cancer risk. Int J Cancer 47, 207-212 (1991).
14. Vena, J. E. et al. Coffee, cigarette smoking, and bladder cancer in western New York. Ann Epidemiol 3, 586-591 (1993).
15. Bruemmer, B., White, E., Vaughan, T. L. & Cheney, C. L. Fluid intake and the incidence of bladder cancer among middle-aged men and women in a three-county area of Western Washington. Nutr Cancer 29, 163-168 (1997).
16. Sala, M. et al. Coffee consumption and bladder cancer in nonsmokers: a pooled analysis of case-control studies in European countries. Cancer Cause Control 11, 925-931 (2000).
17. Woolcott, C. G., King, W. D. & Marrett, L. D. Coffee and tea consumption and cancers of the bladder, colon and rectum. Eur J Cancer Prev 11, 137-145 (2002).
18. Wang, J. et al. Fluid intake, genetic variants of UDP-glucuronosyltransferases, and bladder cancer risk. Br J Cancer 108, 2372-2380 (2013).
19. Wakai, K. et al. Foods and beverages in relation to urothelial cancer: Case-control study in Japan. Int J Urol 11, 11-19 (2004).
20. Villanueva, C. M. et al. Coffee consumption, genetic susceptibility and bladder cancer risk. Cancer Cause Control 20, 121-127 (2009).
21. Ugnat, A. M., Luo, W., Semenciw, R. & Mao, Y. Occupational exposure to chemical and petrochemical industries and bladder cancer risk in four western Canadian provinces. Chronic Dis Can 25, 7-15 (2004).
22. Pujolar, A. E. et al. Bladder cancer and coffee consumption in smokers and nonsmokers in Spain. Int J Epidemiol 22, 38-44 (1993).
23. Pohlabeln, H., Jockel, K. H. & Bolm-Audorff, U. Non-occupational risk factors for cancer of the lower urinary tract in Germany. Eur J Epidemiol 15, 411-419 (1999).
24. Pelucchi, C., La Vecchia, C., Negri, E., Dal Maso, L. & Franceschi, S. Smoking and other risk factors for bladder cancer in women. Prev Med 35, 114-120 (2002).
25. Lu, C.M. et al. Tea consumption: Fluid intake and bladder cancer risk in southern Taiwan. Urology 54, 823-828 (1999).
26. Kunze, E., Chang-Claude, J. & Frentzel-Beyme, R. Life style and occupational risk factors for bladder cancer in Germany: A case-control study. Cancer 69, 1776-1790 (1992).
27. Jiang, X. et al. Water intake and bladder cancer risk in Los Angeles County. Int J Cancer 123, 1649-1656 (2008).
28. Jensen, O. M., Wahrendorf, J., Knudsen, J. B. & Sorensen, B. L. The copenhagen case-control study of bladder cancer. II. Effect of coffee and other beverages. Int J Cancer 37, 651-657 (1986).
29. Geoffroy-Perez, B. & Cordier, S. Fluid consumption and the risk of bladder cancer: Results of a multicenter case-control study. Int J Cancer 93, 880-887 (2001).
30. Donato, F., Boffetta, P., Fazioli, R., Gelatti, U. & Porru, S. Reliability of data on smoking habit and coffee drinking collected by personal interview in a hospital-based case-control study. Eur J Epidemiol 14, 259-267 (1998).
31. Donato, F. et al. Bladder cancer, tobacco smoking, coffee and alcohol drinking in Brescia, northern Italy. Eur J Epidemiol 13, 795-800 (1997).
32. De Stefani, E. et al. Non-alcoholic beverages and risk of bladder cancer in Uruguay. BMC Cancer 7 (2007).
33. D'Avanzo, B., La Vecchia, C., Negri, E., Decarli, A. & Benichou, J. Attributable risks for bladder cancer in Northern Italy. Ann Epidemiol 5, 427-431 (1995).
34. D'Avanzo, B. et al. Coffee consumption and bladder cancer risk. Eur J Cancer 28, 1480-1484 (1992).
35. Covolo, L. et al. Bladder cancer, GSTs, NAT1, NAT2, SULT1A1, XRCC1, XRCC3, XPD genetic polymorphisms and coffee consumption: A case-control study. Eur J Epidemiol 23, 355-362 (2008).
36. Chyou, P. H., Nomura, A. M. & Stemmermann, G. N. A prospective study of diet, smoking, and lower urinary tract cancer. Ann Epidemiol 3, 211-216 (1993).
37. Kurahashi, N., Inoue, M., Iwasaki, M., Sasazuki, S. & Tsugane, S. Coffee, green tea, and caffeine consumption and subsequent risk of bladder cancer in relation to smoking status: A prospective study in Japan. Cancer Sci 100, 284-291 (2009).
38. Michaud, D. S. et al. Fluid intake and the risk of bladder cancer in men. N Engl J Med 340, 1390-1397 (1999).
39. Nagano, J. et al. Bladder-cancer incidence in relation to vegetable and fruit consumption: a prospective study of atomic-bomb survivors. Int J Cancer 86, 132-138 (2000).
40. Tripathi, A., Folsom, A. R. & Anderson, K. E. Risk factors for urinary bladder carcinoma in postmenopausal women - The Iowa women's health study. Cancer 95, 2316-2323 (2002).
41. Link, C. J. Jr. et al Caffeine inhibits gene-specific repair of UV-induced DNA damage in hamster cells and in human xeroderma pigmentosum group C cells. Carcinogenesis 16, 1149-1155 (1995).
42. Vucic, E. A., Brown, C. J. & Lam, W. L. Epigenetics of cancer progression. Pharmacogenomics 9, 215-234 (2008).
43. Bai, Y. et al. Relationship between bladder cancer and total fluid intake: a meta-analysis of epidemiological evidence. World J Surg Oncol 12, 223 (2014).
44. Higgins, J. P., Thompson, S. G., Deeks, J. J. & Altman, D. G. Measuring inconsistency in meta-analyses. BMJ 327, 557-560 (2003).
45. Morrison, A. S. Epidemiology and environmental factors in urologic cancer. Cancer 60, 632-634 (1987).
46. Chung, C. J. et al. The effect of cigarette smoke and arsenic exposure on urothelial carcinoma risk is modified by glutathione S-transferase M1 gene null genotype. Toxicol Appl Pharm 266, 254-259 (2013).
47. Tao, L. et al. Environmental tobacco smoke in relation to bladder cancer risk - the Shanghai bladder cancer study. Cancer Epidem Biomar 19, 3087-3095 (2010).
48. Kurahashi, N., Inoue, M., Iwasaki, M., Sasazuki, S. & Tsugane, S. Coffee, green tea, and caffeine consumption and subsequent risk of bladder cancer in relation to smoking status: a prospective study in Japan. Cancer Sci 100, 294-291 (2009).
49. Zevin, S. & Benowitz, N. L. Drug interactions with tobacco smoking. Clin Pharmacokinet 36, 425-438 (1999).
50. Johansson, S. L. & Cohen, S. M. Epidemiology and etiology of bladder cancer. Semin Surg Oncol 13, 291-298 (1997).
51. Fanlo, A. et al. Urinary mutagenicity, CYP1A2 and NAT2 activity in textile industry workers. J Occup Health 46, 440-447 (2004).
52. Hickman, D. & Sim, E. N-acetyltransferase polymorphism. Comparison of phenotype and genotype in humans. Biochem Pharmacol 42, 1007-1014 (1991).
53. Stroup, D. F. et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283, 2008-2012 (2000).
54. Stang, A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25, 603-605 (2010).
55. Greenland, S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9, 1-30 (1987).
56. Orsini, N. et al. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 175, 66-73 (2012).
57. Lau, J. et al. Quantitative Synthesis in Systematic Reviews. Ann Intern Med 127, 820-826 (1997).
58. Doi, S. A. et al. A quality-effects model for meta-analysis. Epidemiology 19, 94-100 (2008).
59. Begg, C. B. & Mazumdar, M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088-1101 (1994).
60. Egger, M., Davey Smith, G., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629-634 (1997).